Home › COVID-19 and Coronavirus Infections › Pennsylvania › Pittsburgh
COVID-19 and Coronavirus Infections clinical trials in Pittsburgh, PA
3 studies for COVID-19 and Coronavirus Infections are looking for participants at sites in and around Pittsburgh (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
RecruitingPhase 3
- Research Site, Pittsburgh
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
RecruitingPhase 3
- TRC, Pittsburgh
- University of Pittsburgh Medical Center, Pittsburgh
- UPMC Division of Infectious Disease Clinic, Pittsburgh
- and 5 more
Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
RecruitingPhase 3
- University of Pittsburgh Medical Center Health System, Pittsburgh
COVID-19 and Coronavirus Infections trials in other cities
- Washington, DC7 studies
- Dallas, TX5 studies
- Houston, TX5 studies
- Durham, NC5 studies
- Boston, MA5 studies
- Atlanta, GA5 studies
- Los Angeles, CA4 studies
- New York City, NY4 studies
- Hialeah, FL4 studies
- San Francisco, CA3 studies
- Chicago, IL3 studies
- Cincinnati, OH3 studies
Other studies in Pittsburgh
- Non-Small Cell Lung Cancer48 studies
- Cancer (all types)41 studies
- Breast Cancer39 studies
- Colorectal Cancer32 studies
- Metastatic Cancer31 studies
- Melanoma31 studies
- Ovarian Cancer30 studies
- Endometrial Cancer23 studies
- Prostate Cancer23 studies
- Lung Cancer23 studies
- Head and Neck Squamous Cell Carcinoma22 studies
- Stroke22 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.